Angiogenesis in ischemic heart disease

Nature Medicine

Volumn 3, Issue 2, 1997, Pages 158-164

  Anthony Ware, J ^a   Simons, Michael ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; ENDOTHELIUM CELL RECEPTOR; GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIUM GROWTH FACTOR;

ANGIOGENESIS; COLLATERAL CIRCULATION; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; REVIEW;

ANIMALS; CORONARY VESSELS; HUMANS; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PATHOLOGIC;

EID: 16944362446     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0297-158     Document Type: Review

References (16)

1. Fidler, I.J. & Ellis, L.M. The implication of angiogenesis for the biology and therapy of cancer metastasis. Cell 79, 185-88 (1994).
2. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1, 27-31 (1995).
3. Risau, W. & Flamme, I. Vasculogenesis. Ann. Rev. Cell. Dev. Biol. 11, 79-91 (1995).
4. Dvorak, H.F., Brown, L.F., Detmar, M. & Dvorak, A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am. J. Pathol. 146, 1029-1039 (1995).
5. Thomas, K.A. Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem. 271, 603-606 (1996).
6. Olofsson, B. et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 93, 2576-2581 (1996).
7. Joukov, V. et al. A novel vascular endothelial growth factor, VECF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VECFR-2) receptor tyrosine kinases. EMBO J. 15, 290-298 (1996).
8. Ferrara, N. et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442 (1996).
9. Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single EGF allele. Nature 380, 435-439 (1996).
10. Slavin, J. Fibroblast growth factors: at the heart of angiogenesis. Cell. Biol. Int. 19, 431-144 (1995).
11. Folkman, J. & Shing, Y. Angiogenesis. J. Biol. Chem. 267, 10931-10934 (1992).
12. Kuwabara, K. et al. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 92, 4606-1610 (1995).
13. Shweiki, D., Itin, A., Soffer, D. & Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845 (1992).
14. Tuder, R.M., Flook, B.E. & Voelkel, N.F. Increased gene expression for VEGF and the VECF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J. Clin. Invest. 95, 1798-1807 (1995).
15. Li, J. et al. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am. J. Physiol. 270, HI803-H1811 (1996).
16. Sellke, F.W. et al. Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium. Am. J. Physiol. 271, H713-H720 (1996).